ArticleMikrochimica acta2025
A bifunctional monomer molecularly imprinted sensor modified with boronic acid-functionalized carbon dots for detecting azithromycin.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Azithromycin (AZM) is regarded as a potential risk to human immunity and ecosystems, which requires an effective method for rapid on-site detection. Herein, a bifunctional monomer molecularly imprinted polymer and boronic acid-functionalized carbon dots (B-CDs) have been applied to develop an innovative sensor for the determination of AZM. The synergistic effects of boronic esters formation by boronic acid groups and non-covalent interaction of imprinted cavities by pyrrole enhance the binding affinity for improved recognition. In addition, the electrode modification strategy of B-CDs and multiwalled carbon nanotube (MWCNTs) enhance the electron transportation. The constructed sensor exhibited a broad linear detection range (0.2-300 µM), low detection limit (0.12 µM) and significant specificity for AZM (IF = 3.01). Furthermore, it showed satisfactory stability, repeatability and resistance to interference, enabling accurate detection of AZM in milk, serum and urine. This work provides a new avenue for the development of tailored sensitive electrochemical sensors to achieve specific detection.
Indexed as
Identifiers
41315173What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.